Page last updated: 2024-08-21

plumbagin and Carcinoma, Non-Small Cell Lung

plumbagin has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Im, E; Kang, CG; Lee, EO; Lee, HJ1
Guo, J; Ma, K; Ma, Q; Sun, S; Xu, J; Xu, W; Yang, R; Yang, Y; Zhang, J; Zhang, Y1
Fan, XX; Huang, JM; Jiang, ZB; Leung, EL; Ma, YP; Wang, QQ; Wang, W; Wang, XR; Wu, QB; Xie, C; Xie, YJ; Xu, C; Yan, PY; Yao, XJ; Zhang, YZ1
Liu, LX; Shen, H; Shu, YQ; Xu, TP1
Chow, K; Duan, W; He, SM; He, ZX; Huang, GH; Li, M; Li, YC; Liu, A; Liu, JP; Pang, JX; Qiu, JX; Yang, T; Yang, Y; Zhang, X; Zhou, Q; Zhou, SF; Zhou, ZW1

Other Studies

5 other study(ies) available for plumbagin and Carcinoma, Non-Small Cell Lung

ArticleYear
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
    Bioorganic & medicinal chemistry letters, 2017, 05-01, Volume: 27, Issue:9

    Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Movement; Humans; Lung; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplasm Invasiveness; Osteopontin; Plumbaginaceae; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction

2017
Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 146

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Glucose Transporter Type 1; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Naphthoquinones; NF-E2-Related Factor 2; Pyrazoles; Quinolines; Rats; Reactive Oxygen Species; Selenocysteine; Thioredoxin Reductase 1

2022
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8
    Pharmacological research, 2021, Volume: 169

    Topics: ADP-Ribosylation Factor 1; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Down-Regulation; Female; Lung Neoplasms; Lymphocyte Activation; Mice, Nude; Naphthoquinones; Neoplasm Transplantation

2021
Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF- κB inactivation.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:4

    Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Electrophoretic Mobility Shift Assay; Humans; Luciferases; Lung Neoplasms; Naphthoquinones; NF-kappa B; Plumbaginaceae; Protein Transport; Superoxides; Tumor Cells, Cultured

2013
Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
    Cancer letters, 2014, Mar-28, Volume: 344, Issue:2

    Topics: Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Naphthoquinones; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases

2014